Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. - Wikidata - awgldk - TriplyDB

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

http://www.wikidata.org/entity/Q34327750

about

A novel mechanism of action of tetracyclines: effects on nitric oxide synthases Interferon-beta for treatment of rheumatoid arthritis?The Gut Microbiota in Immune-Mediated Inflammatory Diseases Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?Group comparisons involving missing data in clinical trials: a comparison of estimates and power (size) for some simple approaches.Antibiotics for rheumatoid arthritis? Minocycline shows promise in some patients.Enhancement of antinociception by coadministration of minocycline and a non-steroidal anti-inflammatory drug indomethacin in naïve mice and murine models of LPS-induced thermal hyperalgesia and monoarthritis Population Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experiments.Benefits and risks of minocycline in rheumatoid arthritis.Tetracyclines for the treatment of rheumatoid arthritis.How can a causal role for small bacteria in chronic inflammatory arthritides be established or refuted?Minocycline: stain devil?Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.Minocycline suppresses activation of nuclear factor of activated T cells 1 (NFAT1) in human CD4+ T cells American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.Effects of minocycline on Fas-mediated fulminant hepatitis in mice Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study Use of minocycline in viral infections Retention of under-represented minorities in drug abuse treatment studies Randomised double-blind trial of combination antibiotic therapy in rheumatoid arthritis.Minocycline development for acute ischemic stroke Inter-relationships between rheumatoid arthritis and periodontal disease. A review.Antibiotic trials for coronary heart disease.The microbiome and rheumatoid arthritis Therapeutic application of natural inhibitors against snake venom phospholipase A(2).Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects.Should infection still be considered as the most likely triggering factor for rheumatoid arthritis?Use of macrolides and tetracyclines for chronic inflammatory diseases.Drug-induced disorders of teeth.Periodontitis and rheumatoid arthritis: a review.Minocycline for short-term neuroprotection Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline Minocycline: far beyond an antibiotic.Rheumatoid arthritis is an autoimmune disease caused by periodontal pathogens.11C-(R)-PK11195 PET imaging of microglial activation and response to minocycline in zymosan-treated rats.How physician obesity specialists use drugs to treat obesity.Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis.Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.

P2860

Q24680257-24F1AA8C-BEDF-4A11-994D-A21495C04D41 Q24793971-C2F2A3BA-29F3-42CD-96AF-D00E9CE8A3AB Q26741414-496B9237-6F4E-451E-B515-DEE47268CEF1 Q27342233-DB6BFC30-C42D-4FB3-B157-39DDD1180FC1 Q30327329-74A73FD3-2D7E-4D38-9BA1-1491EE1EAABB Q30658786-1AA54988-6298-4C3C-A5B3-3400CBD13D3C Q33605248-908282ED-3DD9-4538-AFF9-A18109491078 Q33759886-66D8311D-BE37-4BC5-B7BE-115B66560101 Q33928776-B8C21387-AFAA-4A4D-8128-7B55B6FB961F Q33929579-2583F66F-6743-426B-BFFA-44A483D92774 Q34074938-9820EC02-B738-4358-B087-F7B377AA4081 Q34136991-637EEC18-F3BD-496A-93F9-795CDFC66354 Q34224517-68AB1384-1F4F-4177-AC4E-8614EEF9E217 Q34655648-EC7558DC-A009-4585-B68B-73E413739ED4 Q34719602-C103821F-727D-4F7C-B296-C24ED58F7B8F Q34782898-57D55A6E-E1A4-4C0D-BDE7-FC0B61D92E94 Q35048549-72F6CAA6-243D-4EA6-B239-BB82F8EF6D80 Q35052651-A10F96B2-CCD7-41C9-9ECC-3226155DBAD1 Q35062807-63199954-F109-4C30-A3E0-8CECADDEC5FA Q35070260-8FDEDB98-AE11-4279-875F-05D3F393BC98 Q35098842-E9F553DA-920D-4958-8700-CE128C55E7D9 Q35202559-D01BE25B-2660-4900-9577-F0FB21195DD2 Q35212215-71407398-B5FB-4E95-8CC1-5CBED1C6CC72 Q35733945-C03AC64A-7253-420C-B59F-7A0D23288ABE Q35743863-BC8B820F-5D54-48F7-8096-B9B3D6ACA453 Q35764977-FBE1A6C8-770A-43E4-970D-B4307BEBE3B5 Q35840805-18F40975-82EE-4726-921D-C2E01E1ED597 Q35915966-CC8DFF32-7AB1-4BB4-BBBD-19BD40C2A7D3 Q35962028-00F84B25-D096-49FE-8D7D-ECBC0439B502 Q36171589-B2AD2A7E-FF17-4BDF-ADD7-EAD4E5295DDB Q36309246-B6053E93-3233-4829-8856-0ED673894A19 Q36428406-36175833-8ABC-4002-89B9-F2CCCE15D512 Q36514428-7D4E84E1-5D60-4840-A0A5-6CDF27D805BF Q36836358-9E781D88-A409-4203-A5F8-DD49EA9EF979 Q36888430-21CFB7BB-513C-4D19-8164-CA358458D78A Q37144048-FC897153-A8F3-4453-B1E2-92F7E1F68F40 Q37418915-7E41BA8E-93D3-4BF3-BEC8-BA126C935ACF Q37498849-B241C638-9978-4D9E-B8CE-9080F8CFE2F7 Q37562665-698D6553-B2CA-433F-B464-ABE6E5F18916 Q37632332-FE12E7CA-180F-4D78-9F08-90654ABCCE38

P2860

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

http://www.wikidata.org/entity/Q34327750

description

1995 nî lūn-bûn

@nan

1995 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Minocycline in rheumatoid arth ...... olled trial. MIRA Trial Group.

@ast

Minocycline in rheumatoid arth ...... olled trial. MIRA Trial Group.

@en

Minocycline in rheumatoid arth ...... olled trial. MIRA Trial Group.

@nl

type

label

Minocycline in rheumatoid arth ...... olled trial. MIRA Trial Group.

@ast

Minocycline in rheumatoid arth ...... olled trial. MIRA Trial Group.

@en

Minocycline in rheumatoid arth ...... olled trial. MIRA Trial Group.

@nl

prefLabel

Minocycline in rheumatoid arth ...... olled trial. MIRA Trial Group.

@ast

Minocycline in rheumatoid arth ...... olled trial. MIRA Trial Group.

@en

Minocycline in rheumatoid arth ...... olled trial. MIRA Trial Group.

@nl

P1433

Q34327750-9A54A4BB-8C2E-4DF8-8ABF-59855465C38A

P1476

Q34327750-54C3B34B-DC48-4E53-82F7-C30A97E61825

P2093

Q34327750-02C2D08C-C601-4568-A19F-C1B5FC443555

Q34327750-071EB8E4-50E7-4738-83BC-0EAE31A8FC0F

Q34327750-0DD12160-026A-415C-B99A-E22E0B9F689A

Q34327750-43DA9011-25D4-4A9F-A376-8F33E84019C3

Q34327750-447F1E2D-E9F6-4145-B092-20A1D879FB4F

Q34327750-4CD5AEF2-AE11-40B2-9FAF-E0CEE9EEBCC4

Q34327750-72366E51-4822-41CB-A037-7F2EB04ACC5B

Q34327750-7A1B879E-3979-4630-BAF4-6DF911FDB4D1

Q34327750-9183E69E-F0AB-400F-8295-0A385AED46CA

Q34327750-93C7A025-AA29-44C2-A084-F250E753F2F5

P304

Q34327750-9B3897B4-A317-4637-A595-959D91F18D4D

P31

Q34327750-0B00A964-2756-443C-9251-DF1ACFA12D0E

P356

Q34327750-974E7CFB-122C-4C80-B98E-F9D7BA3C94AE

P407

Q34327750-7FB8A768-E947-479A-AF53-56516AED3740

P433

Q34327750-E8C6F3C3-7F27-4750-AD46-F141D4CF6DA5

P478

Q34327750-31B936EA-8E5B-4653-9151-1D9E8A0522C3

P577

Q34327750-BD879669-7121-499B-BCA1-834B54684D26

P698

Q34327750-85F34C04-7817-42E0-B653-6C44DDC754F6

P921

Q34327750-C4C6946E-C80B-4F87-8C1D-2C94CAACDC8C

P356

0003-4819-122-2-199501150-00001

P1433

Annals of Internal Medicine

P1476

Minocycline in rheumatoid arth ...... olled trial. MIRA Trial Group.

@en

P2093

Alarcón GS

http://www.w3.org/2001/XMLSchema#string

Buckley L

http://www.w3.org/2001/XMLSchema#string

Clegg DO

http://www.w3.org/2001/XMLSchema#string

Cooper SM

http://www.w3.org/2001/XMLSchema#string

Duncan H

http://www.w3.org/2001/XMLSchema#string

Fowler SE

http://www.w3.org/2001/XMLSchema#string

Heyse SP

http://www.w3.org/2001/XMLSchema#string

Kaplan DA

http://www.w3.org/2001/XMLSchema#string

Leisen JC

http://www.w3.org/2001/XMLSchema#string

Neuner R

http://www.w3.org/2001/XMLSchema#string

P304

81-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-122-2-199501150-00001

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P577

1995-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7993000

http://www.w3.org/2001/XMLSchema#string

P921